Stocks & Investing
Fri, September 27, 2024
[ Fri, Sep 27th 2024
] - WOPRAI
Wed, August 7, 2024
[ Wed, Aug 07th 2024
] - WOPRAI
Thu, May 16, 2024
[ Thu, May 16th 2024
] - WOPRAI
Wed, May 1, 2024
[ Wed, May 01st 2024
] - WOPRAI
Mon, April 1, 2024
[ Mon, Apr 01st 2024
] - WOPRAI
Thu, March 28, 2024
[ Thu, Mar 28th 2024
] - WOPRAI
Wed, March 13, 2024
[ Wed, Mar 13th 2024
] - WOPRAI
Tue, June 13, 2023
[ Tue, Jun 13th 2023
] - WOPRAI
Mon, April 3, 2023
[ Mon, Apr 03rd 2023
] - WOPRAI
Fri, March 3, 2023
[ Fri, Mar 03rd 2023
] - WOPRAI
Tue, February 28, 2023
[ Tue, Feb 28th 2023
] - WOPRAI
Tue, November 22, 2022
Tue, March 15, 2022
[ Tue, Mar 15th 2022
] - WOPRAI
Wed, March 9, 2022
[ Wed, Mar 09th 2022
] - WOPRAI
Wed, January 5, 2022
[ Wed, Jan 05th 2022
] - WOPRAI
Wed, February 3, 2021
[ Wed, Feb 03rd 2021
] - WOPRAI
Mon, January 11, 2021
[ Mon, Jan 11th 2021
] - WOPRAI
Wed, October 31, 2018
[ Wed, Oct 31st 2018
] - WOPRAI
Thu, September 20, 2018
[ Thu, Sep 20th 2018
] - WOPRAI
Thu, May 24, 2018
[ Thu, May 24th 2018
] - WOPRAI
Wed, August 7, 2013
[ Wed, Aug 07th 2013
] - WOPRAI
Alexander Nowak Maintained (BVS) at Strong Buy with Increased Target to $17 on, Sep 27th, 2024
Alexander Nowak of Craig-Hallum, Maintained "Bioventus Inc." (BVS) at Strong Buy with Increased Target from $12 to $17 on, Sep 27th, 2024.
Alexander has made no other calls on BVS in the last 4 months.
There is 1 other peer that has a rating on BVS. Out of the 1 peers that are also analyzing BVS, 0 agree with Alexander's Rating of Hold.
This is the rating of the analyst that currently disagrees with Alexander
- William Plovanic of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $12 on, Tuesday, August 13th, 2024
